Community perspectives on treating asymptomatic infections for malaria elimination in The Gambia. by Jaiteh, Fatou et al.
Jaiteh, Fatou; Masunaga, Yoriko; Okebe, Joseph; D’Alessandro, Um-
berto; Balen, Julie; Bradley, John; Gryseels, Charlotte; Ribera, Joan
Muela; Grietens, Koen Peeters (2019) Community perspectives on
treating asymptomatic infections for malaria elimination in The Gam-
bia. Malaria journal, 18 (1). p. 39. ISSN 1475-2875 DOI: https://doi.org/10.1186/s12936-
019-2672-7
Downloaded from: http://researchonline.lshtm.ac.uk/4651648/
DOI: 10.1186/s12936-019-2672-7
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by/2.5/
Jaiteh et al. Malar J           (2019) 18:39  
https://doi.org/10.1186/s12936-019-2672-7
RESEARCH
Community perspectives on treating 
asymptomatic infections for malaria elimination 
in The Gambia
Fatou Jaiteh1,2,3* , Yoriko Masunaga1,3, Joseph Okebe2, Umberto D’Alessandro2,5, Julie Balen6, John Bradley5, 
Charlotte Gryseels1, Joan Muela Ribera4 and Koen Peeters Grietens1
Abstract 
Background: Innovative and cost-effective strategies that clear asymptomatic malaria infections are required to 
reach malaria elimination goals, but remain a challenge. This mixed methods study explored people’s attitudes 
towards the reactive treatment of compound contacts of malaria cases with a 3-day course of dihydroartemisinin-
piperaquine (DHAP), the socio-cultural representations of asymptomatic infections, and more specifically their 
treatment.
Methods: Prior to the start of the intervention, a sequential mixed method study was carried out. Qualitative 
data collection involved in-depth interviews and participant observations (including informal conversations) with 
key informants from the trial communities and the trial staff. Quantitative data were derived from a pre-trial cross-
sectional survey on health literacy and health-seeking behaviour among randomly selected members of the study 
communities.
Results: In the pre-trial cross-sectional survey, 73% of respondents reported that malaria could be hidden in the 
body without symptoms. Whilst this may be interpreted as people’s comprehension of asymptomatic malaria, qualita-
tive data indicated that informants had different interpretations of asymptomatic disease than the biomedical model. 
It was described as: (i) a minor illness that does not prevent people carrying out daily activities; (ii) an illness that oscil-
lates between symptomatic and asymptomatic phases; and, (iii) a condition where disease agents are present in the 
body but remain hidden, without signs and symptoms, until something triggers their manifestation. Furthermore, this 
form of hidden malaria was reported to be most present in those living in the same compound with a malaria case 
(71%).
Conclusion: Treating asymptomatic malaria with pharmaceuticals was considered acceptable. However, people felt 
uncertain to take treatment without screening for malaria first, largely due to the lack of symptoms. Knowledge of 
asymptomatic malaria was not a strong re-inforcement for treatment adherence. In this study, the pre-intervention 
active engagement of communities existed of having people co-design accurate information messages about their 
personal risk of malaria, which increased their trust in expert knowledge and thus proved essential for the successful 
implementation of the community-based intervention.
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Background
As global strides are made towards malaria elimination, 
the focus of interventions has shifted to include a group 
of people identified as ‘asymptomatic carriers’ and/or 
as the ‘human reservoir of infection’ [1]. The latter are 
defined as malaria-infected but apparently healthy indi-
viduals who may be the source of infection for malaria 
vectors, thereby maintaining transmission [1–4]. In clini-
cal malaria studies, ‘apparently healthy’ usually means the 
absence of fever, the most apparent symptom of malaria 
[5, 6]. Although for other vector-borne diseases, such as 
dengue, the term ‘inapparent symptomatic’ is often used 
[7–9] to implicate the possibility of asymptomatic carri-
ers to encounter (mild) symptoms, the clinical spectrum 
of experienced asymptomatic malaria has not yet been 
clearly defined or elaborated on. In contrast to sympto-
matic infections, asymptomatic malaria infections indeed 
tend to generally be described microbiologically. As such, 
an asymptomatic malaria case exhibits a considerably 
lower parasite density than a symptomatic case crossing 
the threshold of what is detectable by currently available 
diagnostic methods such as light microscopy or a rapid 
diagnostic test (RDT) [10, 11]. Research shows that low 
density infections, including sub-microscopic infections, 
could be important contributors to malaria transmission 
in areas with very low transmission intensity [10, 12, 13]. 
In the context of malaria elimination goals, the possibil-
ity of continuous transmission maintained by undetected 
malaria cases highlights the significance of understand-
ing the ‘human reservoir of infection’ [10, 11, 14].
At low malaria prevalence, identifying asympto-
matic carriers becomes increasingly difficult because 
of the need of screening many individuals to identify a 
few infected ones. Ultra-sensitive molecular methods 
can maximize the detection of lower densities of para-
sites, but are currently not feasible in routine surveil-
lance [11]. A possible approach would be to treat the 
whole population, regardless of malaria infection status, 
with an efficacious anti-malarial, i.e. mass drug admin-
istration (MDA). However, with the currently available 
treatments, this approach automatically excludes some 
population groups, such as pregnant women or infants 
under 6 months old, while other groups, such as mobile 
populations, would be easily missed. Furthermore, both 
MDA and alternatives such as scheduled screening and 
treatment (SST) are difficult to sustain over long periods 
of time, particularly when transmission has decreased 
to very low levels, due to population fatigue, logisti-
cal challenges and costs. Targeting sub-groups or geo-
graphical areas may be an alternative approach but has 
similar shortcomings [1, 5, 6]. Lastly, reactive case detec-
tion (RCD), a strategy in which household members of 
a passively identified clinical malaria case are screened 
and treated if positive, has the limitation of the current 
diagnostic tools in detecting low density infections [15]. 
Furthermore, RCD may not be sustainable in the short or 
long term in low to moderate transmission settings [16] 
as it may require active commitment of the populations 
involved [17].
To overcome these limitations, reactive household-
based, self-administered treatment (RHOST) was tested 
through a cluster-randomized trial in a low prevalence 
setting of The Gambia. The concept and the trial protocol 
have been published elsewhere [18]. The trial proposed 
an innovative approach for targeting the human reser-
voir of infection by combining: i) the passive detection 
of clinical malaria cases; ii) systematic treatment without 
screening with dihydroartemisinin-piperaquine (DHAP) 
of all individuals living/sleeping in the index case’s com-
pound; and, iii) an active community participation by 
means of involving patients, their households and other 
community actors in tackling implementation concerns 
and co-designing solutions according to their knowledge 
and experience.
One of the key challenges for the optimal impact of 
interventions targeting asymptomatic individuals is their 
adherence to medication while not being apparently sick 
[19]. As a malaria elimination programme in the Solo-
mon Islands showed, despite community engagement 
and education, people were unwilling to take drugs on 
repeated MDA rounds because they were not sick [20]. 
As other studies have also shown [21–26], understanding 
and consequently adapting intervention strategies to peo-
ple’s perceptions of asymptomatic infections is crucial for 
the effectiveness of such community-based interventions. 
Complex biomedical concepts such as asymptomatic 
infections are difficult to elaborate on with the communi-
ties targeted for MDA when using only biomedical lan-
guage [22, 23, 27, 28].
Perceptions of malaria in sub-Saharan Africa have fre-
quently been shown to be different from the biomedical 
model, consequently influencing the uptake of interven-
tions [29–32]. Furthermore, concepts from traditional 
and biomedical knowledge sources can syncretize to pro-
duce hybridized perceptions of malaria [33, 34]. These 
findings have stimulated the development and inspired 
the design of culturally appropriate information, edu-
cation and communication (IEC) strategies to improve 
intervention uptake. However, it is also widely acknowl-
edged that improving knowledge through well designed 
IEC strategies does not automatically lead to changed 
health behaviour [34]. There is limited understanding on 
how asymptomatic malaria is understood by recipients of 
MDA, and how these perceptions affect the implemen-
tation and/or the uptake of the intervention. This study, 
set within the context of a cluster-randomized trial that 
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included key community participation and engagement 
component, focused on understanding and contextual-
izing the perceptions of asymptomatic malaria and its 
treatment.
Methods
Study setting
Study population
This mixed methods study was carried out in the North 
Bank Region of The Gambia. The main ethnic groups 
residing in these villages are Fula, Mandinka and Wollof, 
although there are other minority groups: Bambara, Tili-
bonka and Turkas, that migrated from neighbouring Mali 
and Burkina Faso. Most are Muslims. Each ethnic group 
speaks their own language, although Mandinka or Fula 
is the common language for communication and trade. 
Farming is the most common occupation, with peanuts 
as the main cash crop, while rice, maize, beans, and veg-
etables are grown for own consumption. A significant 
number of families supplement their income through 
remittances from relatives living either in the major 
towns or abroad.
Malaria context
Malaria transmission in the area is seasonal, low (trans-
mission prevalence of 5%) and occurs mostly between 
July and December. The main malaria parasite is Plasmo-
dium falciparum [35].
Trial context
The trial was a cluster-randomized trial designed to 
assess the impact of reactive treatment of contacts of a 
clinical malaria case living in the same compound on the 
prevalence of malaria infection at the end of the trans-
mission season. It was planned over two transmission 
seasons. In the first season (preparatory phase), study 
villages (17 intervention, 17 control) were identified and 
approaches to integrate the intervention into the com-
munities and health system were tested and adapted by 
social scientists and health system researchers through 
formative research. During this process, trial implemen-
tation concerns were identified and solutions co-devel-
oped with relevant stakeholders, including community 
members, health service providers and policy makers. 
The final health messages for sensitization, including the 
medicine distribution strategy involving key community 
actors such as village health workers (VHWs) and com-
pound heads developed for community members to sup-
port the intervention, were applied in all intervention 
villages in the second season (implementation phase).
Study design
As part of the formative research during the preparatory 
phase, a sequential exploratory mixed-methods study 
was conducted, in standard annotation (QUAL → quan) 
[36]. In the first qualitative strand (March–May 2016), 
ethnographic techniques were used in all intervention 
villages (n = 17) to understand the general socio-cultural, 
political and economic context, including an overview 
of all health care options in the region. People’s percep-
tions on asymptomatic malaria were also explored during 
this phase. Based on the qualitative findings, a question-
naire was developed for the cross-sectional survey in the 
sequential quantitative strand (June 2016). The survey 
assessed the representativeness of the qualitative findings 
in all the study villages (n = 34).
Qualitative strand
Participants and sampling
In the qualitative study, sampling was theoretical mean-
ing that informants were purposefully and gradually 
selected based on emerging findings. Access to the 
informants was usually granted through snowball sam-
pling, where initial participants are used to identify and 
connect the researchers with other theoretically relevant 
informants. The Alkalo (village head) was a starting point 
to gradually and purposefully select other people from 
the study villages, including recent malaria cases (individ-
uals diagnosed by rapid diagnostic test (RDT) by a health 
worker) and their caretakers, compound heads, VHWs 
and marabouts (traditional healers). From the trial team, 
study nurses and fieldworkers were also included. Sam-
pling aimed for maximum variation to ensure that all 
relevant groups in relation to the research question were 
included.
Data collection
In‑depth interviews
Data collection began by carrying out in-depth inter-
views with the Alkalos who were identified as gatekeep-
ers to the communities and knowledgeable on the general 
socio-cultural, political, economic, and pluralistic medi-
cal context. In their roles as gatekeepers and source of 
reference, they identified households recently affected 
with malaria and/or other key informants, which helped 
to build trust with the interviewees. The focused inquiry 
with key informants involved the in-depth exploration 
of topics such as the concept of asymptomatic malaria 
infection, the processes and metaphors used to describe 
asymptomatic conditions, and the acceptability of treat-
ing asymptomatic individuals with anti-malarials. Inter-
views were conducted by the authors (FJ and JM) with 
the help of two translators. The interviews were recorded 
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and transcribed verbatim by the translators. Additionally, 
during interviews, field notes were written by FJ and JM 
for immediate analysis.
Participant observation
During the fieldwork, informal conversations were con-
ducted with community members, trial nurses and field-
workers. These conversations were useful to confirm or 
refute emerging findings and generate new hypotheses 
for testing.
Data analysis
Data analysis was a flexible and iterative process. Pre-
liminary data from in-depth interviews and participant 
observations were jointly analysed by FJ and JM to fur-
ther adapt the interview guide and process. Additional 
data collection was used to confirm or refute temporary 
findings until the point of saturation (i.e. no new findings 
emerging). All interviews were systematized and ana-
lysed with NVivo 11 Qualitative analysis software (QSR 
International Pty Ltd, Cardigan UK).
Quantitative strand
Participants and sampling
Participants were identified using a bootstrap sampling 
technique with the population stratified by household 
and age (children (< 16 years) and adults). The sampling 
frame ensured that the number of households selected 
was in proportion to the size of the village. The question-
naire for children was administered to caregivers and 
where any of the initially selected persons were unavail-
able, the next person in the household in the same age 
category was approached to complete the questionnaire.
Data collection
A paper-based questionnaire containing closed-ended 
and open-ended questions was used to collect quantita-
tive data. Topics included health-seeking behaviour for 
malaria, health literacy including knowledge on asymp-
tomatic malaria carriers, adherence to malaria treatment 
and trust in different health providers. The survey was 
piloted by the social science team to ensure clarity and 
to avoid translation errors in the three main languages. 
Survey data were collected by the social science team and 
trial fieldworkers previously trained on interview tech-
niques and administering questionnaires with closed and 
open-ended questions.
Data analysis
All completed survey forms were double entered in Excel 
by trial data entry clerks, verified by the social science 
team and cleaned using Epi Info. Data were analysed 
using STATA 15 (Stata Corp, Tx). For this manuscript, 
frequencies for variables related to asymptomatic carri-
ers are presented. These are presented stratified by gen-
der, ethnicity, education level and socio-economic status. 
Chi squared tests were used to assess whether differences 
were statistically significant. Socio-economic status was 
calculated from questions related to education, hous-
ing, income and employment using principal component 
analysis.
Ethical approval
Ethical approval was obtained from the joint Gambia 
Government/Medical Research Council Unit The Gam-
bia Ethics Committee and the Institutional Review Board 
of the Institute of Tropical Medicine, Antwerp, Belgium. 
The interviewers followed the Code of Ethics of the 
American Anthropological Association. All interviewees 
were informed before the interview about the topic and 
types of questions and their right to decline participation, 
to interrupt or withdraw from the conversation. Oral 
consent was sought before each interview and was doc-
umented by the interviewer. Oral consent was favoured 
since the risk was minimal and the act of signing one’s 
name on a document was expected to cause mistrust 
towards the study team since this is not customary prac-
tice within the local communities. Interviewees confiden-
tiality was assured by assigning unique identifiers to the 
collected forms.
Results
Study participants
Qualitative strand
In-depth interviews (n = 88) and informal conversations 
(n = 5) were carried out with community members and 
field staff (Table 1).
Table 1 Overview of  respondents for  in-depth interviews 
and informal conversations
Participants In-depth 
interviews
Informal 
conversations
Village heads (Alkalos) 8
Alkalo’s brother 2
Alkalo’s son 1
Alkalo’s wife 1
Marabout (healer) 2
Malaria case caregiver (women) 2
Farmer (men) 42
Farmer (women) 30
Field staff (men) 5
Total 88 5
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Quantitative strand
In total, 741 questionnaires were completed; there were 
no refusals; 324 adults and 417 children (< 16 years) ques-
tionnaires were completed. The questionnaire for chil-
dren (< 16  years) was administered to their caretakers 
(Table 2).
Conceptualization of asymptomatic carriage
There were no local terms in the commonly spoken local 
languages, i.e. Mandinka, Fula and Wolof, corresponding 
directly to ‘asymptomatic disease’. Consequently, asymp-
tomatic disease was explained as a health condition 
where a disease is present, but the affected person does 
not feel any signs and symptoms related to the disease. 
Based on this explanation, respondents interpreted the 
statement to mean a health condition where disease was 
present in the body but did not affect one’s appetite nor 
restricted their ability to carry out daily activities. The 
condition, to which everyone was considered susceptible, 
was understood as covering the following scenarios: (i) 
a minor illness which mild symptoms does not prevent 
people from carrying out daily activities; (ii) an illness 
that oscillates between symptomatic and asymptomatic 
phases; and, (iii) a condition where disease agents are 
present in the body but remain hidden until something 
triggers their manifestation in apparent symptoms. Dur-
ing the asymptomatic phase, the so-called ‘body soldiers’ 
(i.e. a representation of antibodies provided in health 
messages) are fighting the hidden disease but produce 
no apparent symptoms. Symptoms only appear when 
the body soldiers are defeated in the presence of exter-
nal triggering factors. The elaborated local model of ill-
ness progression for asymptomatic conditions therefore 
presents the following characteristics: (i) everyone is sus-
ceptible to an asymptomatic condition; (ii) the disease 
can remain hidden for a variable period, depending on 
the fight in the body (body soldiers); (iii) symptoms will 
manifest when body soldiers are defeated or when cer-
tain triggers occur; (iv) disease can be transmitted even 
in asymptomatic form; and, (v) asymptomatic conditions 
should be treated when they become symptomatic.
Perceptions of asymptomatic malaria
Several diseases (biomedical) and folk illnesses (illnesses 
that do not correspond to any biomedical classifications 
of diseases), such as yellow fever, worms, lung tuberculo-
sis, jinn (spirits) afflictions and malaria, were considered 
having asymptomatic stages within the local explanatory 
model of health and illness. However, these distinct bio-
medical conditions were not always perceived to be dis-
tinct locally and were reported to naturally evolve into 
one another.
Malaria was described as one of the conditions that 
could be asymptomatic. The majority of respondents 
(73%) thought that malaria can be hidden in the body 
without showing symptoms (Table  3). The proportions 
of those who thought so were similar across gender, 
ethnicity, educational level and socio-economic status. 
Respondents in the survey considered this form of hid-
den malaria most likely to be present in those living in 
the same household with a malaria case (71%), with no 
statistically significant differences across the socio-
demographic characteristics (Table  3). Similarly, 78% of 
respondents stated that living in the same household as 
someone having malaria increased their personal risk 
of getting malaria. This varied by whether the respond-
ent thought malaria could be asymptomatic, with 80% 
of those who thought malaria could be asymptomatic 
considering they were at increased risk as compared to 
69% of those who did not (p = 0.002). 91% of respondents 
reported having a mosquito net in the home, and this 
did not vary by whether the respondent thought malaria 
could be asymptomatic or not (91%) and 88% of net use 
respectively (p = 0.168).
Qualitative interviews indicated that asymptomatic 
malaria was perceived to be hidden in different parts of 
the body and frequently in the head and joints where 
pain is first experienced.
Table 2 Socio-demographic characteristics respondents 
in quantitative study (N = 741)
n %
Gender
 Male 308 41.6
 Female 423 57.1
 Missing 10 1.3
Ethnicity
 Mandinka 385 52.0
 Fula 221 29.8
 Wolof 50 6.7
 Tilibonka 34 4.6
 Bambara 27 3.6
 Turkai 5 0.7
 Other 19 2.6
Knows how to read (English)
 Yes 108 14.5
 No 630 85.0
Occupation (adults and caretakers of participating minors [< 16])
 Farmer 673 90.8
 Public officer 6 0.8
 Business 41 5.53
 Other 21 2.83
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“Generally, diseases can be housed in different parts 
of the body. Most times, for malaria the head is the 
problem and it starts with that place.” (Adult man, 
Farmer)
The time it takes for malaria symptoms to appear var-
ied depending on a combination of factors such as: (i) 
one’s ability to withstand or cope with illness represented 
by the concept of ‘body strength’ and, (ii) the duration 
the body soldiers of the affected individual fights. For 
instance, the period of pregnancy was considered a phase 
of low body strength and thus pregnant women were 
perceived to have weaker body soldiers. Following these 
logics, the strength of the body (i.e. blood or body sol-
diers) can be increased or nourished by consuming cer-
tain foods such as green leafy vegetables and decreased 
through hard work and taking cold baths. This illustra-
tion reinforces the notion that one is asymptomatic when 
the body is strong and can thus hide the disease. When 
the body is weakened by the culmination of a set of exter-
nal triggers (i.e. sun, milk, hard work), the symptoms of 
the disease can no longer be hidden and start to emerge. 
Most of the respondents (91%) thought that if malaria 
was hidden in the body, hot sun can make the symp-
toms appear. This perception significantly varied across 
ethnicity (Mandinka (95%), Wolof (91%) and Fula (83%), 
P < 0.001), and socio-economic levels (wealthiest quartile 
(89%), 2nd quartile (91%), 3rd quartile (97%) and poor-
est quartile (88%), p = 0.043) (Table  3). Among those 
who thought that if malaria was hidden in the body, 85% 
reported that drinking milk could make the symptoms 
appear, with similar proportions across socio-demo-
graphic characteristics.
It was widely acknowledged that mosquitoes could 
directly cause malaria (99.8%) and increased malaria risk 
was associated with mosquito density, which was related 
to stagnant water. Another commonly mentioned way of 
contracting malaria was ‘body heat’ transfer, understood 
as the transmission of heat (and disease) through direct 
(e.g. sleeping together with a malaria case) or indirect 
(e.g. sleeping in the place where a malaria case person 
was sleeping before) contact. In addition, the dormant 
state of malaria could be triggered to an active state by a 
mosquito bite (89%) (with similar proportions across the 
socio-demographic characteristics), resulting in apparent 
Table 3 Perceptions of  asymptomatic infections in  relation to  socio-demographic characteristics [% of  respondents 
affirming the statement (n/N)]
Hidden malaria 
in the body
Increased risk in same 
household
Mosquito bites trigger 
symptoms
Hot sun triggers 
symptoms
Drinking 
milk triggers 
symptoms
Total 73% (538/736) 71% (416/586) 89% (520/585) 91% (533/587) 85% (498/586)
Gender
 Male 74% (225/306) 71% (172/243) 87% (210/242) 89% (216/243) 85% (206/243)
 Female 73% (306/421) 71% (240/336) 91% (306/336) 92% (310/337) 85% (286/336)
 p-value 0.800 0.865 0.100 0.205 0.909
Ethnicity
 Mandinka 74% (285/383) 74% (218/296) 90% (267/296) 95% (283/297) 87% (257/297)
 Fula 73% (159/219) 67% (125/186) 88% (163/185) 83% (155/186) 82% (152/185)
 Wolof 60% (30/50) 58% (19/33) 79% (26/33) 91% (30/33) 82% (27/33)
 Other 76% (64/85) 76% (54/71) 90% (64/71) 92% (65/71) 87% (62/71)
 p-value 0.162 0.108 0.245 < 0.001 0.517
Education level
 None 72% (380/530) 70% (290/416) 88% (366/415) 91% (378/417) 85% (355/417)
 Primary 78% (113/144) 76% (91/119) 92% (109/119) 90% (107/119) 84% (100/119)
 Secondary 76% (29/38) 63% (20/32) 88% (28/32) 100% (32/32) 87% (27/31)
 p-value 0.242 0.207 0.563 0.182 0.905
Socio-economic status quartile
 Wealthiest 80% (143/178) 73% (108/148) 92% (139/151) 89% (135/152) 84% (128/152)
 2nd 73% (132/180) 73% (105/144) 88% (117/132) 91% (121/133) 81% (107/132)
 3rd 69% (124/179) 68% (91/133) 88% (128/145) 97% (140/145) 89% (129/145)
 Poorest 73% (133/181) 69% (105/152) 87% (129/148) 88% (130/148) 86% (127/148)
 p-value 0.118 0.745 0.562 0.043 0.313
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symptoms such as fever, headache, vomiting and body 
aches.
When malaria is related to and often even equated 
with the folk illness joontinoji (Fula), it is perceived to 
progress from its symptomatic phase to yellow fever 
(Chawnabee-Fula).
“When malaria has power, it can change into yellow 
fever” (Adult farmer, Talen Fula).
This progression was said to be more common dur-
ing the rainy season. Yellow fever, locally referred to as 
Chawnabee (Fula), Sumuyaa (Tilibonka), Sai (Tilibonka) 
and Paices (Wollof ), was believed to affect mostly chil-
dren. The symptoms (yellowing of the eyes and vomit, 
fever, the changing colours of the palms of the hands) 
appear temporarily and then the disease hides again. 
The appearance of the symptoms is triggered by the con-
sumption of specific food items, such as milk, which were 
more commonly available during the rainy season. Dur-
ing the symptomatic phase the disease can be transmit-
ted to others by looking into the sick person’s eyes.
Perceptions of anti-malarial treatment for asymptomatic 
carriers
Diagnosis and uncertainty
Although most people accepted that malaria could be 
asymptomatic, people do not actively seek treatment 
when symptoms are absent. People perceived analgesics 
(paracetamol or ibuprofen) taken after experiencing mild 
malaria symptoms to strengthen the body enough so it 
can hide the remaining malaria. Such hidden malaria is 
then considered undetectable by biomedical diagnostic 
tools, such as RDTs.
Anti‑malarial treatment for asymptomatic malaria
Informants generally considered it unnecessary to take 
medication without having any symptoms. However, 
when anti-malarial treatment is given after screening and 
the individual found to be positive, it was perceived to be 
a necessary means of disease prevention. This is consist-
ent with local practices of self-protection with amulets or 
charms commonly referred to as fankanta (Mandinka) to 
prevent ailments such as jinn afflictions, common child-
hood illnesses or the ‘evil eye’ during women’s pregnancy. 
Once anti-malarial medication is consumed after screen-
ing, the medication is perceived to increase the body’s 
strength, enabling it to engage in a fight with the disease. 
In contrast to analgesics, malaria medication strength-
ens the body to the point where it can eliminate the dis-
ease rather than hide it. During this process, the blood 
becomes hot, making people sweat. Observed sweating 
after taking anti-malarial treatment was therefore seen as 
evidence of treatment efficacy.
“If you take anti-malarial treatment, it goes into the 
blood to fight what it is meant to fight. If you take the 
pills, it goes through the blood, which gets hot to fight 
the disease and when you sweat, then they say that 
you are feeling better from malaria and the medi-
cine is good for you.” (Adult man, Farmer)
The efficacy of the anti-malarial medication was also 
perceived to be contingent on the prior ‘body strength’ of 
the individual. As a result, there was a general notion that 
individuals differed substantially and therefore that the 
treatment might work for some (eliminating the disease) 
and fail for others (hiding the disease only). The failure 
of treatment for some individuals was also attributed to 
the perceived strength of the anti-malarial medication 
in relation to its dosage. Especially taking an incomplete 
anti-malarial regimen could trigger the symptoms to 
reappear.
Attitudes towards health workers
77% of respondents said they received good or very 
good advice from the VHWs. This varied by whether the 
respondent thought malaria could be asymptomatic, with 
73% of those who thought malaria could be asympto-
matic receiving good or very good advice, compared to 
86% of those who did not (p = 0.002). 95% of respondents 
said they received good or very good advice from the per-
sonnel at the health facility. This did not vary by whether 
the respondent thought malaria could be asymptomatic, 
with 95% of those who thought malaria could be asymp-
tomatic receiving good or very good advice, compared 
to 93% of those who did not (p = 0.235). Qualitative data 
further showed that trust in health workers (VHWs and 
health facility personnel) was relatively high. However, 
the main limitation for VHWs which generated dis-
trust in the community was the common complaint that 
the provision of RDTs and treatment was continuously 
deteriorating.
Discussion
This study explored how local perspectives on asymp-
tomatic carriage were structured in relation to specific 
health interventions. Perceptions of asymptomatic car-
riage reflect a dynamic understanding of health and ill-
ness, where every individual is vulnerable to hidden 
conditions where disease agents are constantly per-
ceived to be engaged in a battle with the body’s defences 
(i.e. body soldiers). If the body soldiers are defeated, 
the body’s ability to resist or cope with illness (body 
strength) diminishes, leading to manifestation of the 
symptoms of the disease. Similarly, in a study carried out 
on perceptions of vaccinations in The Gambia, medical 
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interventions such as immunizations were perceived as 
protecting the health of the child by giving ‘strength’ or 
‘power’ to withstand or cope with illness [37].
For some conditions such as yellow fever and malaria, 
the manifested symptoms are seen as interchange-
able, thereby representing the transformative nature of 
asymptomatic conditions. The perceived elements mak-
ing up the disease process inside the body, mirrors both 
components from local knowledge systems related to 
‘hidden diseases’ described elsewhere [25, 29, 37, 38], 
and biomedical health information related to the body’s 
defence mechanism with antibodies. Indeed, in the study 
area, there has been a long presence of health campaign 
groups, including malaria programmes, that use meta-
phoric terms such as body soldiers in their health promo-
tion activities in order to explain the process of natural 
immunity against parasites and other invading pathogens 
in the body [37]. Furthermore, the knowledge on body 
soldiers are conceptually linked to more general notions 
of body and blood strength. Following these logics, the 
act of consuming certain foods such as green leafy vege-
tables to strengthen the body soldiers to withstand illness 
could be compared to the perceived protective nature of 
pharmaceuticals and vaccinations to strengthen the body.
In relation to asymptomatic malaria and its treatment, 
this merging of different knowledge systems is neither 
arbitrary nor incoherent, as it follows an internal logic of 
disease transformations (from asymptomatic to sympto-
matic, malaria to yellow fever), which was key for under-
standing people’s acceptance of the condition as relevant. 
These findings also support recommendations to move 
away from the term ‘asymptomatic’ malaria in favour 
of ‘chronic malaria’ [10], or even ‘inapparent sympto-
matic’ as used for other infections [9]. Such a reconcep-
tualization would allow for a clinical spectrum of mild 
symptoms, disease progressions and associated co-mor-
bidities, which the assumption of a ‘benign’ asympto-
matic infection without any clinical symptoms does not 
currently support.
Implications for MDA strategies including reactive mass 
treatment
The perception of malaria to be potentially asymptomatic 
was relatively high with most respondents believing that 
living in the same household as someone having malaria 
increased their personal risk of getting malaria. Qualita-
tive data supported illness progression pathways where 
malaria is perceived to hide, grow and eventually mani-
fest when triggered by external factors. This concept of 
illness progression was often used to explain events post 
facto or for narrative purposes and was therefore not a 
strong determinant for adhering to malaria preventive 
measures. The asymptomatic infection was a key cause 
of diagnostic uncertainty, which has been described to 
occur in  situations where the decision-maker cannot 
assign definite values to objects and events and/or an 
individual is unable to predict outcomes because suf-
ficient cues are lacking [39]. Because they had a clear 
understanding of malaria symptoms, the lack of these 
symptoms in asymptomatic phases led to a state of 
uncertainty exemplified by respondents’ insistent ques-
tions of how they could be aware of having the disease 
when they did not experience any symptoms. Previous 
studies on asymptomatic conditions have shown that 
uncertain outcomes related to one not knowing whether 
they had a disease that was asymptomatic were reasons 
for treatment refusal or abandonment [25, 40].
However, unlike the findings of the malaria elimina-
tion programme in the Solomon Islands where asymp-
tomatic individuals were not considered as sick and 
refused treatment, most of our informants ascertained 
anti-malarials to cure malaria even if the disease was 
in a dormant phase. Furthermore, the study population 
showed willingness to accept RDT positive results in the 
absence of symptoms. Since 2008, there has been a signif-
icant roll-out in The Gambia of RDTs with artemisinin-
based combined therapy (ACT) including the availability 
and accessibility to long-lasting insecticide-treated bed 
nets (LLINs) and indoor residual spraying (IRS) for 
malaria control [41]. These developments are reported 
to have contributed to the reduction of malaria burden 
[35]. Although current conventional tests cannot detect 
asymptomatic infections, the positive perceptions held 
by this population on the accuracy of positive diagnostic 
results highlight the need for the continuous strengthen-
ing of health worker capacity, especially VHWs to effec-
tively manage malaria cases.
In the situation of diagnostic uncertainties highlighted 
by this study, the authority of and trust in an expert may 
become more important than people’s perceptions of 
health and illness. This warrants an active engagement of 
communities in research projects in order to strengthen 
their trust in biomedical specialists’ diagnosis and health 
information on particular malaria risks in this context. 
This further relates to the expectation that when pursu-
ing malaria elimination, programmes will find themselves 
working in and with communities that progressively 
adapt their perceptions of malaria risk to decreasing 
incidence [42]. Interventions designed to actively engage 
communities could provide an opportunity to re-estab-
lish or heighten awareness of malaria risk and thereby 
foster trust in health authorities.
Strength and limitations
This study is the first in-depth analysis of community’s 
understanding on the concept of asymptomatic malaria 
Page 9 of 10Jaiteh et al. Malar J           (2019) 18:39 
infections and its implication for malaria elimination in 
West-Africa. There is evidence from South East Asia and 
East Africa depicting populations misunderstandings 
on asymptomatic malaria infections and willingness to 
take treatment in MDAs [25, 26, 43]. A recent publica-
tion from Laos in the context of antimalarial resistance 
in the Greater Mekong sub-Region highlights the need 
for MDA interventions with accompanying community 
engagements to build trust with different stakeholders 
[26]. By using a mixed-methods approach our work dem-
onstrated the logic behind the study population’s under-
standing of asymptomatic infections in order to highlight 
before implementation, the facilitators and barriers of 
adherence for improving acceptability of the strategy. The 
study population’s acknowledgement of the increased 
risk of asymptomatic malaria for individuals sharing the 
same compound with a symptomatic malaria case (71%) 
could be influenced by pre-intervention information 
spread through the community, nonetheless, it signifies 
the relevance of understanding perceived malaria trans-
mission dynamics.
Conclusion
This study on perspectives of asymptomatic malaria 
infections in The Gambia highlights that people’s percep-
tion of illness progression could make elimination strate-
gies targeting asymptomatic individuals acceptable in the 
local context. However, due to the uncertainty of future 
manifestations of malaria symptoms, these perceptions 
do not currently act as a motivation for treatment adher-
ence. To address the issue of diagnostic uncertainty, 
elimination strategies will need to actively engage com-
munities to foster trust in expert knowledge.
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